Home > Healthcare > Medical Devices > Diagnostic Devices > Automated Immunoassay Analyzers Market

Automated Immunoassay Analyzers Market Size

Report ID: GMI1727
Published Date: May 2023
Report Format: PDF

Download Free Sample

Automated Immunoassay Analyzers Market Size

Automated Immunoassay Analyzers Market size crossed USD 16.9 billion in 2022 and is slated to depict around 14.3% CAGR from 2023 to 2032.

To get key market trends

Download Free Sample

Recent trends related to automation and integration of advanced technologies has led to introduction of innovative products in the market. Numerous biotechnology and pharmaceutical companies are increasingly using such products for drug discovery, allergy testing, among various other purposes. Increasing prevalence of infectious diseases, novel product launches, growing range of clinical applications of immunoassay analyzers are other variables that are anticipated to propel the product adoption rate. In addition, such aforementioned factors are set to cumulatively drive the automated immunoassay analyzers industry growth.

Automated Immunoassay Analyzers Market Report Attributes
Report Attribute	Details
Base Year:	2022
Automated Immunoassay Analyzers Market Size in 2022:	16.9 Billion USD
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	14.3%
2032 Value Projection:	67.7 Billion USD
Historical Data for:	2018 to 2022
No. of Pages:	210
Tables, Charts & Figures:	476
Segments covered:	Product, Application, End-use and Region
Growth Drivers:	Incessant introduction of advanced products Rising trend towards lab automation Increasing prevalence of infectious diseases
Pitfalls & Challenges:	Expanding clinical applications of immunoassay analyzers Dearth of qualified and trained professionals

Learn more about the key segments shaping this market

Download Free Sample

An immunoassay analyzer is an advanced tool used in hospitals and laboratories to automate the process of analyzing immunoassays and run biochemical tests to detect the presence and concentration of substances in the given samples. It is a compact, easy to use machine that delivers fast and reliable results.

The automated immunoassay analyzers market is likely to impede tremendous growth due to dearth of qualified and trained professionals in healthcare sector. With the growing elderly population across the world, there is an increasing need for qualified professionals in healthcare facilities such as hospitals, diagnostics, and reference laboratories. Thus, lack of well-trained professionals to maintain the minimum standards of healthcare is predicted to hamper the industry growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The size of automated immunoassay analyzers industry was valued at USD 16.9 billion in 2022 and will reach over USD 67.7 billion in 2032, attributed to the growing prevalence of infectious illnesses, novel product launches, and growing range of clinical use of immunoassay analyzers.

The chemiluminescence segment was worth USD 5.3 billion in 2022 as a result of the high accuracy and sensitivity of the diagnosis using low analyte concentration.

The hospital end-use segment is anticipated to witness a 14.7% CAGR from 2023 to 2032 owing to the rising number of people suffering from heart and lung disorders, increasing awareness levels, and facilitative reimbursement schemes.

North America automated immunoassay analyzers market is predicted to reach over USD 23.2 billion by 2032 propelled by the increasing prevalence of infectious diseases, different allergies, and cancer in the region.